Subscribe By E-Mail

Home » Archives by category » Asia

Stocks viewed as cutting through the talk of gloom

Deep discounts to net asset value and the pricing in of negative factors linked to a property downturn have prompted some analysts to take a positive view on the stocks…

China’s crackdown on overpriced IPOs shows effect

Mainland companies marketing initial share sales are settling for lower valuations than most investors are willing to pay, evidence that a central government crackdown on overpriced deals is yielding results.…

IPO resumption adds to bearish mood for equities

Just how much can the upcoming initial public offerings raise in the struggling stock market on the mainland?┬áLast week, Beijing officially opened the floodgates for new share flotations after a…

Funds will return to Asian bonds, says Fuss

Dan Fuss, the legendary investor dubbed the Warren Buffett of the bond world, says the Asian bond market is on the road to recovery after concerns over developing markets prompted…

Capital flows to rebalance from Asia to developed markets this year, analysts say

Rebalancing will be the theme for the global economy this year, with a strengthening recovery in developed markets drawing attention and capital away from Asia, analysts say in their annual…

Stockbrokers to lobby for lower stamp duties

Stockbrokers plan to lobby the government to reduce the stamp duty on stock transactions to help boost market turnover. Markets & Investing feed…

After belated securities reform, Hong Kong should look at insurance regulation

Twenty-five years after it was proposed, the Hong Kong stock exchange is finally going to implement a key reform that will bring it in line with late-20th century practice. In…

Singapore considers tougher IPO rules

Regulators in Singapore are planning to issue a consultation paper that will propose tighter rules for companies looking to list in the city-state, months after the stock exchange was hit…

Betting on China pays off for Asian hedge funds

For investors in Asian hedge funds, it was China and not the region’s hottest major market, Japan, that provided the best bang for the buck last year – a result…

Chinese drug maker Aosaikang dashes IPO hopes

Hopes for an initial public offering bonanza on the mainland were dashed yesterday after drug maker Jiangsu Aosaikang Pharmaceutical halted its fundraising process because of concerns it was too big.…

Page 1 of 122123Next ›Last »